A highly significant correlation was found between the two assay systems, which both discriminated between patients with stable and active disease, the highest propeptide levels being recorded in patients with a syndrome of acute myelofibrosis and those with accelerated disease [ 91 ].
← all excerpts
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
1
—
—